FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308381829> ?p ?o ?g. }

• W4308381829 abstract "<h3>Background</h3> Real-world data (RWD) and real-world evidence (RWE) has long been used in drug development programs: to help generate hypotheses and assess the feasibility of clinical trials, or for post-marketing surveillance purposes. There is a wealth of RWD sources; data can be gathered from medical records, registries and wearables, among others. This data is then analysed to obtain RWE. Today, RWD/RWE is also increasingly being used to support regulatory decisions, especially during market authorisation approval for new drugs or new indications. A number of immuno-oncology drug products have owed their approval to the use of RWD/RWE. <h3>Methods</h3> The objective of this experiment is to identify and trace the regulatory history of selected immuno-oncology products to understand how RWD/RWE has been applied in their drug development programs to market, and the perspective of the regulators at the time of review. Using Cedience, we identify the RWD/RWE-generating trials used in an immuno-oncology drug’s submission. Cedience is a next-generation regulatory intelligence platform that allows a user to answer regulatory precedent questions, monitor topics of interest, and analyse past development strategies by using a database of documents compiled from various regulatory agencies. We have previously used Cedience to identify drug products associated with RWD/RWE and reconstruct a timeline of said drug products by collecting correspondence letters from the FDA. <h3>Results</h3> Using Cedience, case studies were built that show the timeline of a drug’s regulatory history; a picture of the drug’s journey through development. This timeline focuses on RWD/RWE-generating trials used to examine the immuno-oncology drug, as well as the evidence available prior to said trials. In the context of these regulatory submissions, RWD/RWE functions to support randomised clinical trials by providing a second source of data that is more generaliseable to the wider population. <h3>Conclusions</h3> From this data, an analysis of how RWD/RWE was used in the real world could be seen: what percentage of FDA approvals are RWD/RWE-backed, the clinical evidence that can be generated from RWD/RWE, and what type of study designs are appropriate for the generation of RWD/RWE. The regulator’s perspective could be seen as well: how they evaluate RWD/RWE, and whether any issues or concerns are raised." @default.
• W4308381829 created "2022-11-11" @default.
• W4308381829 creator A5002592215 @default.
• W4308381829 creator A5025535247 @default.
• W4308381829 creator A5067623810 @default.
• W4308381829 date "2022-11-01" @default.
• W4308381829 modified "2023-09-25" @default.
• W4308381829 title "1418 Exploring RWE RWD-backed regulatory decisions in immuno-oncology" @default.
• W4308381829 doi "https://doi.org/10.1136/jitc-2022-sitc2022.1418" @default.
• W4308381829 hasPublicationYear "2022" @default.
• W4308381829 type Work @default.
• W4308381829 citedByCount "0" @default.
• W4308381829 crossrefType "proceedings-article" @default.
• W4308381829 hasAuthorship W4308381829A5002592215 @default.
• W4308381829 hasAuthorship W4308381829A5025535247 @default.
• W4308381829 hasAuthorship W4308381829A5067623810 @default.
• W4308381829 hasBestOaLocation W43083818291 @default.
• W4308381829 hasConcept C112930515 @default.
• W4308381829 hasConcept C126322002 @default.
• W4308381829 hasConcept C127413603 @default.
• W4308381829 hasConcept C132964779 @default.
• W4308381829 hasConcept C142724271 @default.
• W4308381829 hasConcept C166957645 @default.
• W4308381829 hasConcept C199360897 @default.
• W4308381829 hasConcept C21547014 @default.
• W4308381829 hasConcept C2522767166 @default.
• W4308381829 hasConcept C2778917124 @default.
• W4308381829 hasConcept C2780035454 @default.
• W4308381829 hasConcept C2780511413 @default.
• W4308381829 hasConcept C41008148 @default.
• W4308381829 hasConcept C4438859 @default.
• W4308381829 hasConcept C535046627 @default.
• W4308381829 hasConcept C64903051 @default.
• W4308381829 hasConcept C71924100 @default.
• W4308381829 hasConcept C95457728 @default.
• W4308381829 hasConcept C98274493 @default.
• W4308381829 hasConceptScore W4308381829C112930515 @default.
• W4308381829 hasConceptScore W4308381829C126322002 @default.
• W4308381829 hasConceptScore W4308381829C127413603 @default.
• W4308381829 hasConceptScore W4308381829C132964779 @default.
• W4308381829 hasConceptScore W4308381829C142724271 @default.
• W4308381829 hasConceptScore W4308381829C166957645 @default.
• W4308381829 hasConceptScore W4308381829C199360897 @default.
• W4308381829 hasConceptScore W4308381829C21547014 @default.
• W4308381829 hasConceptScore W4308381829C2522767166 @default.
• W4308381829 hasConceptScore W4308381829C2778917124 @default.
• W4308381829 hasConceptScore W4308381829C2780035454 @default.
• W4308381829 hasConceptScore W4308381829C2780511413 @default.
• W4308381829 hasConceptScore W4308381829C41008148 @default.
• W4308381829 hasConceptScore W4308381829C4438859 @default.
• W4308381829 hasConceptScore W4308381829C535046627 @default.
• W4308381829 hasConceptScore W4308381829C64903051 @default.
• W4308381829 hasConceptScore W4308381829C71924100 @default.
• W4308381829 hasConceptScore W4308381829C95457728 @default.
• W4308381829 hasConceptScore W4308381829C98274493 @default.
• W4308381829 hasLocation W43083818291 @default.
• W4308381829 hasOpenAccess W4308381829 @default.
• W4308381829 hasPrimaryLocation W43083818291 @default.
• W4308381829 hasRelatedWork W1537699525 @default.
• W4308381829 hasRelatedWork W2060992471 @default.
• W4308381829 hasRelatedWork W2113832503 @default.
• W4308381829 hasRelatedWork W2255799423 @default.
• W4308381829 hasRelatedWork W2372770165 @default.
• W4308381829 hasRelatedWork W2797786689 @default.
• W4308381829 hasRelatedWork W2907095034 @default.
• W4308381829 hasRelatedWork W2930920482 @default.
• W4308381829 hasRelatedWork W3035677853 @default.
• W4308381829 hasRelatedWork W4308381829 @default.
• W4308381829 isParatext "false" @default.
• W4308381829 isRetracted "false" @default.
• W4308381829 workType "article" @default.